查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971336

Piperazine市場－全球產業規模、佔有率、趨勢、機會、預測：按原料、應用、區域和競爭對手分類，2021-2031年

Piperazine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Natural, Synthetic), By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球Piperazine市場預計將從 2025 年的 35.6 億美元成長到 2031 年的 46.3 億美元，複合年成長率為 4.48%。

該市場以環狀乙烯胺化合物為核心，這些化合物是農藥、聚合物和藥品生產的重要中間體。推動這一成長的主要因素是汽車和建築業對環氧固化劑的需求不斷成長。在這些行業中，Piperazine衍生物對於提高塗料和黏合劑的耐熱性和耐久性至關重要。此外，獸醫和人類醫學領域對驅蟲藥的穩定需求也提供了堅實的消費基礎，確保了儘管整個行業存在波動，但需求仍然強勁。

市場概覽
預測期 2027-2031
市場規模：2025年 35.6億美元
市場規模：2031年 46.3億美元
複合年成長率：2026-2031年 4.48%
成長最快的細分市場 合成
最大的市場 亞太地區

根據印度基礎化學品、化妝品和染料出口促進委員會（CHEMEXCIL）的數據，2023-24會計年度印度有機化學品出口額（包括Piperazine等胺類中間體）達75.4億美元。儘管貿易表現強勁，但由於嚴格的健康、環境和安全法規結構，該市場仍面臨許多障礙。例如，環保機構近期提案對Piperazine引入「新重大活動（SNAC）」申報要求，這可能導致合規成本增加和供應鏈複雜性上升，從而可能阻礙關鍵地區的市場擴張。

市場促進因素

Piperazine市場擴張的主要驅動力是工業氣體處理和氣體脫硫領域的成長。特別是，該化合物作為胺類清洗製程的加速劑的有效性發揮了重要作用。隨著工業脫碳壓力的不斷增加，碳捕獲與封存（CCS）技術的應用正在加速，從而推動了對高效溶劑（例如Piperazine活性甲基二乙醇胺（MDEA））的需求。全球捕碳封存研究院（Global CCS Institute）的《2024年全球情勢報告》強調了這一趨勢，該報告指出，一旦目前正在建設的計劃投入運作，全球二氧化碳捕獲能力預計將加倍，達到每年1億噸以上，從而鞏固了對胺類溶劑的長期需求趨勢。

此外，受非專利抗精神病藥物和驅蟲藥生產擴張的推動，醫藥級Piperazine的需求不斷成長，進一步鞏固了市場成長。哌嗪（包括Piperazine哌嗪）是人用和獸用藥物中廣泛使用的活性藥物成分（API）的基本組成部分，亞洲主要製造地正在擴大出口以滿足全球需求。根據印度品牌股權基金會（IBEF）預測，到2025年，印度的藥品出口額預計將達到303.8億美元，凸顯了仿製學名藥供應鏈的龐大規模。為了支持這些多樣化的應用，亨斯邁公司等領先製造商報告稱，2025年過去12個月的銷售額為57.8億美元，反映出高性能產品和胺類藥物領域的顯著經濟活動。

市場挑戰

嚴格的環境和健康安全法規結構是全球Piperazine市場成長的主要障礙。環境保護機構正在加強對各項嚴格通訊協定的執行力度，例如“新重大活動（SNAC）通知要求”，該要求規定在進行進口或生產活動之前，必須提交詳細的報告並進行廣泛的安全測試。這些合規義務迫使製造商將資金重新投入合規方面，而不是研發或擴大產能。因此，核准所需前置作業時間的延長正在擾亂供應鏈，並導致汽車和製藥行業關鍵應用所需的Piperazine衍生物供應延遲。

這種高度合規的環境營造了一種限制性的氛圍，抑制了整個產業的生產。當生產商面臨不斷上漲的非營運成本和法律上的不確定性時，整個化學產業的產量往往會萎縮，對專業市場產生負面影響。根據歐洲化學工業理事會（Cefic）的數據，2024年，高成本和結構性挑戰導致歐盟化學品產量較前一年下降8.0%。這一萎縮清楚地表明，經濟和監管壓力正在直接抑制Piperazine等化學中間體的發展勢頭。

市場趨勢

隨著Piperazine單體在高性能COPOLYAMIDES（尤其是在電子和汽車產業）的應用日益廣泛，市場格局正在重塑。製造商正利用Piperazine合成特殊半結晶質和非晶態聚醯胺，與標準尼龍相比，這些聚醯胺具有更優的透明度、抗衝擊性和熱穩定性。這些尖端材料正成為耐用電子機殼和輕量化汽車零件的關鍵零件，從而推動了對高純度Piperazine的持續需求。這一成長也反映在財務表現上，BASF公佈2024年第三季銷售額達34億歐元，較去年同期成長近2%，主要得益於這些關鍵應用領域銷售的成長。

同時，Piperazine功能化材料在下一代生物農藥領域的開發正開闢新的成長點。隨著農業向永續作物保護轉型，Piperazine衍生物正被用作新型生物活性化合物的骨架，這些化合物具有環境毒性低、靶向性強的優點。這一趨勢得到了業界對環保農藥解決方案的大量投資的支持。根據歐洲作物生命協會（CropLife Europe）發布的《2024年度回顧》，過去八年中，業界已在生物農藥領域投資24億歐元，用於開發與傳統農藥互補的生物農藥，這凸顯了現代農業在拓展胺類中間體效用的戰略轉變。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球Piperazine市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依原料（天然、合成）分類
    • 按應用領域（藥品、農藥、個人護理/化妝品、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美Piperazine市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲Piperazine市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區Piperazine市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲Piperazine市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲哌Piperazine市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球Piperazine市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BASF SE
  • Dow Inc.
  • Evonik Industries AG
  • Solvay SA
  • Albemarle Corporation
  • Shell plc
  • Huntsman Corporation
  • Akzo Nobel NV
  • Diamines and Chemicals Limited（DACL）
  • Shaoxing Xingxin New Materials Co., Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27710

The Global Piperazine Market is projected to expand from USD 3.56 Billion in 2025 to USD 4.63 Billion by 2031, reflecting a compound annual growth rate of 4.48%. This market centers on a cyclic ethyleneamine compound that acts as a crucial intermediate in the production of agricultural chemicals, polymers, and pharmaceuticals. Key drivers for this growth include the rising demand for epoxy curing agents in the automotive and construction sectors, where piperazine derivatives are vital for improving the thermal stability and durability of coatings and adhesives. Additionally, the consistent need for anthelmintic medications in both veterinary and human healthcare provides a reliable consumption base, ensuring demand remains resilient despite broader industrial fluctuations.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.56 Billion
Market Size 2031USD 4.63 Billion
CAGR 2026-20314.48%
Fastest Growing SegmentSynthetic
Largest MarketAsia Pacific

According to the Basic Chemicals, Cosmetics & Dyes Export Promotion Council (CHEMEXCIL), India's exports of organic chemicals-including amine intermediates like piperazine-were valued at USD 7.54 billion in the fiscal year 2023-24. Despite these robust trade figures, the market confronts significant hurdles due to strict regulatory frameworks concerning health and environmental safety. For example, recent proposals by environmental agencies to implement Significant New Activity (SNAC) notification requirements for piperazine could elevate compliance costs and complicate supply chains, potentially obstructing market expansion in major jurisdictions.

Market Driver

A primary force expanding the piperazine market is the growth in industrial gas treatment and gas sweetening, specifically due to the compound's effectiveness as a promoter in amine scrubbing processes. As industries face increasing pressure to decarbonize, the adoption of Carbon Capture and Storage (CCS) technologies has accelerated, driving the need for efficient solvents like activated methyldiethanolamine (MDEA) that rely on piperazine. This trend is highlighted by the Global CCS Institute's 'Global Status Report 2024', which notes that global CO2 capture capacity is on track to double to over 100 million tonnes per year (Mtpa) once current construction projects are operational, securing a long-term demand trajectory for amine-based solvents.

Market growth is further solidified by the rising demand for pharmaceutical-grade piperazine, driven by the expanding production of generic antipsychotic and anthelmintic medications. The compound serves as a fundamental building block for piperazine citrate and other active pharmaceutical ingredients (APIs) used widely in human and veterinary medicine, with major Asian manufacturing hubs ramping up exports to meet global needs. According to the India Brand Equity Foundation (IBEF), Indian pharmaceutical exports reached US$ 30.38 billion in FY25, underscoring the massive scale of the generic drug supply chain. To sustain these diverse applications, key manufacturers like Huntsman Corporation reported a trailing twelve-month revenue of USD 5.78 billion in 2025, reflecting substantial economic activity in performance products and amines.

Market Challenge

Strict regulatory frameworks regarding environmental and health safety represent a major obstacle to the growth of the Global Piperazine Market. Environmental agencies are increasingly enforcing rigorous protocols, such as Significant New Activity (SNAC) notification requirements, which mandate detailed reporting and extensive safety testing before importing or manufacturing activities can proceed. These compliance obligations force manufacturers to divert capital toward regulatory adherence instead of R&D or capacity expansion. Consequently, the extended lead times needed for approvals disrupt supply chains and delay the availability of piperazine derivatives for essential applications in the automotive and pharmaceutical sectors.

This high-compliance environment creates a restrictive atmosphere that dampens overall industrial output. When producers encounter elevated non-operational costs and legal uncertainties, production volumes in the broader chemical sector often contract, negatively affecting specialized markets. According to the European Chemical Industry Council (Cefic), in 2024, chemical output in the European Union recorded a decline of 8.0 percent during the previous year due to high costs and structural challenges. This contraction illustrates how intense economic and regulatory pressures directly restrain the momentum of chemical intermediates like piperazine.

Market Trends

The market is being reshaped by the increasing integration of piperazine monomers into high-performance copolyamides, particularly within the electronics and automotive sectors. Manufacturers are using piperazine to synthesize specialized semi-crystalline and amorphous polyamides that offer superior transparency, impact resistance, and thermal stability compared to standard nylons. These advanced materials are becoming critical for durable electronic housings and lightweight vehicle components, driving sustained demand for high-purity piperazine grades. This surge is reflected in financial performance; according to BASF, the Engineering Plastics business generated sales of €3.4 billion in the third quarter of 2024, an increase of almost two percent driven primarily by higher volumes in these core applications.

Simultaneously, the development of piperazine-functionalized materials for next-generation bio-pesticides is opening a new growth frontier. As the agricultural industry shifts toward sustainable crop protection, piperazine derivatives are being utilized as scaffolds for novel bio-active compounds that provide targeted pest control with lower environmental toxicity. This trend is supported by significant industry investment in green agrochemical solutions. According to CropLife Europe's 'Annual Review 2024', the sector has invested €2.4 billion in biopesticides over the past eight years to complement conventional tools, highlighting the strategic shift expanding the utility of amine-based intermediates in modern agriculture.

Key Market Players

  • BASF SE
  • Dow Inc.
  • Evonik Industries AG
  • Solvay S.A.
  • Albemarle Corporation
  • Shell plc
  • Huntsman Corporation
  • Akzo Nobel N.V.
  • Diamines and Chemicals Limited (DACL)
  • Shaoxing Xingxin New Materials Co., Ltd

Report Scope

In this report, the Global Piperazine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Piperazine Market, By Source

  • Natural
  • Synthetic

Piperazine Market, By End-use

  • Pharmaceutical
  • Agrochemicals
  • Personal Care & Cosmetics
  • Others

Piperazine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Piperazine Market.

Available Customizations:

Global Piperazine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Piperazine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Natural, Synthetic)
    • 5.2.2. By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Piperazine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Piperazine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Piperazine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Piperazine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By End-use

7. Europe Piperazine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Piperazine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Piperazine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Piperazine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Piperazine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Piperazine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By End-use

8. Asia Pacific Piperazine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Piperazine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Piperazine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Piperazine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Piperazine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Piperazine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Piperazine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Piperazine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Piperazine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Piperazine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By End-use

10. South America Piperazine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Piperazine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Piperazine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Piperazine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Piperazine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BASF SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Dow Inc.
  • 15.3. Evonik Industries AG
  • 15.4. Solvay S.A.
  • 15.5. Albemarle Corporation
  • 15.6. Shell plc
  • 15.7. Huntsman Corporation
  • 15.8. Akzo Nobel N.V.
  • 15.9. Diamines and Chemicals Limited (DACL)
  • 15.10. Shaoxing Xingxin New Materials Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer